Responses of the cardiovascular system of the rat to noradrenaline infusions and their modification by adrenoceptor blocking agents
- PMID: 18245
- PMCID: PMC1667195
- DOI: 10.1111/j.1476-5381.1977.tb16755.x
Responses of the cardiovascular system of the rat to noradrenaline infusions and their modification by adrenoceptor blocking agents
Abstract
1 The effects of noradrenaline upon the cardiovascular system of the rat, anaesthetized with pentobarbitone, have been investigated.2 Noradrenaline produces a dose-dependent increase in mean arterial blood pressure (MABP) which is due entirely to an increase in cardiac output; total peripheral vascular resistance (TPR) remains unchanged.3 Following beta-adrenoceptor blockade the pressor response to infused noradrenaline is enhanced and is now due mainly to an increase in TPR; the increment in cardiac output is reduced.4 After alpha-adrenoceptor blockade the pressor response is greatly reduced; the residual increase in MABP is due solely to an increase in cardiac output.5 After ganglion blockade resting cardiac output and TPR both fall, resulting in a reduction in MABP. The pressor response to noradrenaline is enhanced and is now due to increases in both TPR and in cardiac output.6 The cardiovascular response of the anaesthetized rat to noradrenaline can be explained in terms of classical alpha- and beta-adrenoceptor stimulation by the amine; the unusual form of the response may be due to an effective predominance of beta-adrenoceptor-mediated effects in this species.7 It is suggested that the failure of exogenous noradrenaline to produce a rise in TPR results from a balance between the alpha-adrenoceptor-mediated increase and beta-adrenoceptor-mediated decrease in this variable. However, this proposed balance is lost if resting vasoconstrictor tone is reduced by ganglion blockade.
Similar articles
-
Responses of the cardiovascular system of the rat to alpha-and beta-adrenoceptor agonists.Br J Pharmacol. 1977 May;60(1):107-14. doi: 10.1111/j.1476-5381.1977.tb16754.x. Br J Pharmacol. 1977. PMID: 18244 Free PMC article.
-
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.Br J Pharmacol. 1972 Aug;45(4):660-75. doi: 10.1111/j.1476-5381.1972.tb08125.x. Br J Pharmacol. 1972. PMID: 4404413 Free PMC article.
-
Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.Br J Pharmacol. 1975 Apr;53(4):585-92. doi: 10.1111/j.1476-5381.1975.tb07398.x. Br J Pharmacol. 1975. PMID: 238705 Free PMC article.
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
-
Pharmacology of combined alpha-beta-blockade. I.Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003. Drugs. 1984. PMID: 6151889 Review.
Cited by
-
Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.Br J Clin Pharmacol. 1979 Apr;7(4):401-3. doi: 10.1111/j.1365-2125.1979.tb00953.x. Br J Clin Pharmacol. 1979. PMID: 375960 Free PMC article. Clinical Trial. No abstract available.
-
Cardiovascular responses of rats to intrahypothalamic injection of carbachol and noradrenaline.Br J Pharmacol. 1983 Jul;79(3):693-700. doi: 10.1111/j.1476-5381.1983.tb10006.x. Br J Pharmacol. 1983. PMID: 6652349 Free PMC article.
-
The subdivision of beta-adrenoceptors in the cardiovascular system of the rat.Br J Pharmacol. 1979 Nov;67(3):367-70. doi: 10.1111/j.1476-5381.1979.tb08689.x. Br J Pharmacol. 1979. PMID: 227513 Free PMC article.
-
Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients.Br J Clin Pharmacol. 1982 Dec;14(6):833-7. doi: 10.1111/j.1365-2125.1982.tb02045.x. Br J Clin Pharmacol. 1982. PMID: 6129884 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources